(Q40098490)

17 September 2017

title

In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD. (English)

1 reference

17 September 2017

1 reference

6

1 reference

17 September 2017

9

Catherine Ghezzi

1 reference

17 September 2017

Lucie Sancey

1

1 reference

17 September 2017

Valérie Ardisson

2

1 reference

17 September 2017

Laurent M Riou

3

1 reference

17 September 2017

Mitra Ahmadi

4

1 reference

17 September 2017

Danièle Marti-Batlle

5

1 reference

17 September 2017

Pascal Dumy

7

1 reference

17 September 2017

Daniel Fagret

8

1 reference

17 September 2017

Jean-Philippe Vuillez

10

1 reference

17 September 2017

language of work or name

1 reference

4 August 2007

1 reference

17 September 2017

number of pages

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

17 September 2017

volume

34

1 reference

17 September 2017

issue

12

1 reference

17 September 2017

page(s)

2037-2047

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-007-0497-z

17 September 2017

exact match

0 references

cites work

Role of angiogenesis in tumor growth and metastasis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-007-0497-Z

RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathways.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-007-0497-Z

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

12 December 2020

Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation

1 reference

12 December 2020

Design, Synthesis, and Evaluation of Radiolabeled Integrin αvβ3 Receptor Antagonists for Tumor Imaging and Radiotherapy

1 reference

12 December 2020

Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer

1 reference

12 December 2020

MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle.

1 reference

12 December 2020

Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides

1 reference

12 December 2020

Get a ligand, get a life: integrins, signaling and cell survival

1 reference

12 December 2020

Integrins: molecular targets in cancer therapy

1 reference

12 December 2020

Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies

1 reference

12 December 2020

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

1 reference

12 December 2020

Tumor angiogenesis: therapeutic implications

1 reference

12 December 2020

In vivo noninvasive optical imaging of receptor-mediated RGD internalization using self-quenched Cy5-labeled RAFT-c(-RGDfK-)(4).

1 reference

12 December 2020

Pharmacokinetics and renal handling of 99mTc-labeled peptides

1 reference

12 December 2020

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

12 December 2020

Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone

1 reference

12 December 2020

Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression

1 reference

12 December 2020

Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts

1 reference

12 December 2020

Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.

1 reference

12 December 2020

Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells

1 reference

12 December 2020

Noninvasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4.

1 reference

12 December 2020

The RGD story: a personal account

1 reference

12 December 2020

Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography

1 reference

12 December 2020

New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors

1 reference

12 December 2020

Correlation between the tumoral expression of beta3-integrin and outcome in cervical cancer patients who had undergone radiotherapy

1 reference

12 December 2020

Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients

1 reference

12 December 2020

microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide

1 reference

12 December 2020

New perspectives in cell adhesion: RGD and integrins

1 reference

12 December 2020

alphavbeta3 integrin-dependent endothelial cell dynamics in vivo

1 reference

12 December 2020

Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide

1 reference

12 December 2020

Preparation and functional evaluation of RGD-modified proteins as alpha(v)beta(3) integrin directed therapeutics.

1 reference

12 December 2020

Comparative evaluation of linear and cyclic 99mTc-RGD peptides for targeting of integrins in tumor angiogenesis

1 reference

12 December 2020

Spectrum of radiopharmaceuticals in nuclear oncology.

1 reference

12 December 2020

Integrins: versatility, modulation, and signaling in cell adhesion

1 reference

12 December 2020

Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation

1 reference

12 December 2020

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours

1 reference

12 December 2020

Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumour

1 reference

12 December 2020

Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide

1 reference

12 December 2020

The role of integrins in tumor angiogenesis

1 reference

12 December 2020

The alpha v beta 3 integrin "vitronectin receptor"

1 reference

12 December 2020

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

12 December 2020

Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands.

1 reference

12 December 2020

Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis

1 reference

12 December 2020

10.1007/S00259-007-0497-Z

Identifiers

DOI

1 reference

17 September 2017

1 reference